Pharmaceutical Data Integrity Compliance Audit Checklist [FREE PDF]

Data integrity compliance is a cornerstone of pharmaceutical manufacturing, governed by FDA 21 CFR Part 11 for electronic records and 21 CFR 210/211 for cGMP documentation standards. Regulatory agencies including FDA, EMA, and WHO require that all data generated during manufacturing be Attributable, Legible, Contemporaneous, Original, and Accurate (ALCOA+). Failures in data integrity have resulted in Warning Letters, import alerts, and facility shutdowns, making systematic auditing critical for

  • Industry: Pharmaceutical Manufacturing
  • Frequency: Quarterly
  • Estimated Time: 60-90 minutes
  • Role: QA Analyst
  • Total Items: 35
  • Compliance: FDA 21 CFR Part 11 - Electronic Records and Signatures, FDA 21 CFR 211.68 - Automatic, Mechanical, and Electronic Equipment, FDA 21 CFR 211.188 - Batch Production and Control Records, ICH Q7 Section 6 - Documentation and Records, WHO Technical Report Series No. 996 Annex 5 - Data Integrity Guidance

ALCOA+ Principles Verification

Verify that all records meet ALCOA+ data integrity principles as required by cGMP regulations.

  • Are all data entries attributable to the individual who performed the action, with no shared logins observed?
  • Are all records legible, permanent, and not subject to erasure or alteration without a documented audit trail?
  • Are data entries recorded contemporaneously at the time the action is performed, not retrospectively?
  • Are original raw data retained and accessible, with no records replaced by copies without justification?
  • Are complete records maintained including all repeat analyses, invalidated results, and any data that did not meet specifications?

Electronic Systems and Part 11 Compliance

Assess compliance of computerized systems with FDA 21 CFR Part 11 requirements for electronic records and signatures.

  • Are all computerized systems used for GMP records validated and documented under a formal computer validation protocol?
  • Is the audit trail function enabled, active, and reviewed regularly for all GMP-relevant electronic systems?
  • Are electronic signatures unique to one individual and not reused or reassigned to another person?
  • Are user access controls configured with role-based permissions preventing unauthorized data modification?
  • Are system clocks synchronized across all GMP computerized systems to a verified, authoritative time source?
  • Is there a procedure to review and approve audit trails as part of batch record review or periodic data review?

Batch Records and Documentation Controls

Review batch production and laboratory records for completeness, accuracy, and compliance with cGMP documentation standards.

  • Do batch production records include all required information specified in the master batch record without gaps or missing entries?
  • Are all corrections to paper records made with a single line strikethrough, signed, dated, and accompanied by a reason?
  • Are laboratory notebooks and analytical records reviewed and countersigned by a second qualified person?
  • Are out-of-specification (OOS) results documented and investigated using a formal OOS investigation procedure?
  • Are data transfer processes from analytical instruments to electronic systems validated to prevent transcription errors?

Laboratory Data Integrity Controls

Evaluate laboratory systems, instrument data, and analytical record integrity.

  • Are all laboratory instruments (HPLC, GC, balances, etc.) linked to validated software that captures raw chromatographic data?
  • Are analyst workstations protected from unauthorized access, with screen locks active during unattended periods?
  • Are all sample injections, including failed sequences, aborted runs, and repeat injections, retained in the system audit trail?
  • Is there a formal procedure for the review of chromatographic integration parameters, preventing subjective or undocumented manual integration?
  • Are reference standards and reagents used in testing controlled, labeled, and traceable to a certificate of analysis?

Training and Personnel Accountability

Verify that personnel involved in GMP data generation are adequately trained on data integrity principles and procedures.

  • Have all GMP personnel received documented training on the site's data integrity policy and ALCOA+ principles?
  • Are training records current, complete, and accessible for all personnel who generate or review GMP data?
  • Is there a documented data integrity policy signed by site management that communicates zero tolerance for data falsification?
  • Is there a confidential reporting mechanism for personnel to report potential data integrity concerns without fear of retaliation?
  • Are periodic self-inspections or internal audits conducted that specifically assess data integrity practices?

Data Backup, Archiving, and Retention

Confirm that data backup, disaster recovery, and long-term archiving practices meet regulatory retention requirements.

  • Are electronic GMP records backed up regularly, with backup procedures validated and backup media verified for data integrity?
  • Are backup copies stored in a secure, separate location from the primary system to ensure disaster recovery capability?
  • Are GMP records retained for the minimum required period (e.g., 3 years post-expiry for batch records) per applicable regulations?
  • Is access to archived data restricted and logged, with no unauthorized modification possible after archiving?
  • Are data migration procedures validated to ensure no data loss or corruption when transferring records between systems or storage media?

CAPA and Risk Management for Data Integrity

Review corrective and preventive actions and risk assessment processes related to data integrity findings.

  • Have all previous data integrity observations and findings been addressed through documented CAPA with verified effectiveness checks?
  • Has a formal data integrity risk assessment been conducted to identify high-risk data systems and processes?
  • Are data integrity metrics (e.g., audit trail review frequency, OOS rates, deviation trends) monitored and reported to site management?
  • Are data integrity observations from regulatory inspections (Warning Letters, 483s) reviewed and incorporated into the site's risk assessment?

Related Pharmaceutical Checklists

Related Documentation Checklists

Why Use This Pharmaceutical Data Integrity Compliance Audit Checklist [FREE PDF]?

This pharmaceutical data integrity compliance audit checklist [free pdf] helps pharmaceutical manufacturing teams maintain compliance and operational excellence. Designed for qa analyst professionals, this checklist covers 35 critical inspection points across 7 sections. Recommended frequency: quarterly.

Ensures compliance with FDA 21 CFR Part 11 - Electronic Records and Signatures, FDA 21 CFR 211.68 - Automatic, Mechanical, and Electronic Equipment, FDA 21 CFR 211.188 - Batch Production and Control Records, ICH Q7 Section 6 - Documentation and Records, WHO Technical Report Series No. 996 Annex 5 - Data Integrity Guidance. Regulatory-aligned for audit readiness and inspection documentation.

Frequently Asked Questions

What is a Pharmaceutical Data Integrity Compliance Audit Checklist [FREE PDF]?

A Pharmaceutical Data Integrity Compliance Audit Checklist [FREE PDF] is a standardized inspection form used by qa analyst to ensure consistent pharmaceutical manufacturing operations. It contains 40 inspection points organized into 7 sections. FREE pharmaceutical data integrity audit checklist PDF. Covers FDA 21 CFR Part 11, ALCOA+ principles & cGMP documentation compliance.

How often should I use this pharmaceutical manufacturing checklist?

This checklist is designed to be completed quarterly. Regular use ensures compliance with FDA 21 CFR Part 11 - Electronic Records and Signatures and FDA 21 CFR 211.68 - Automatic, Mechanical, and Electronic Equipment and helps identify issues before they become problems.

Can I download this Pharmaceutical Data Integrity Compliance Audit Checklist [FREE PDF] as a PDF?

Yes, you can download this checklist as a FREE PDF for printing or offline use. The checklist includes 40 fields across 7 sections and typically takes 60-90 minutes to complete.

What compliance standards does this checklist cover?

This checklist helps ensure compliance with FDA 21 CFR Part 11 - Electronic Records and Signatures, FDA 21 CFR 211.68 - Automatic, Mechanical, and Electronic Equipment, FDA 21 CFR 211.188 - Batch Production and Control Records, ICH Q7 Section 6 - Documentation and Records, WHO Technical Report Series No. 996 Annex 5 - Data Integrity Guidance. Following these standards protects your organization and ensures best practices.

How do I complete this pharmaceutical manufacturing inspection checklist?

Begin by completing the header fields for Inspection Date and Time, Inspector Name, Facility / Site Name, Audit Reference Number, and Audit Scope. Work through each of the 7 sections, marking items Yes or No as applicable. The entire process takes approximately 60 to 90 minutes.

What are the key sections in this pharmaceutical manufacturing checklist?

This pharmaceutical manufacturing checklist is organized into 7 key sections: ALCOA+ Principles Verification, Electronic Systems and Part 11 Compliance, Batch Records and Documentation Controls, Laboratory Data Integrity Controls, Training and Personnel Accountability, Data Backup, Archiving, and Retention, CAPA and Risk Management for Data Integrity. Each section contains specific inspection points that qa analyst must verify. The structured layout ensures nothing is missed during pharmaceutical manufacturing inspections and makes the process efficient, typically taking 60-90 minutes to complete.

Who should use this Pharmaceutical Data Integrity Compliance Audit Checklist [FREE PDF]?

This checklist is primarily designed for qa analyst working in pharmaceutical manufacturing operations. However, it is also valuable for quality assurance teams, safety officers, compliance managers, and supervisors who need to verify that pharmaceutical manufacturing standards are being met. Organizations of all sizes can benefit from using this Pharmaceutical Data Integrity Compliance Audit Checklist [FREE PDF] to maintain consistency and accountability.

Browse More Checklists

POPProbe